Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings

The aim of the study was identifying the features of infection in the site, clinical course of the disease, amount and frequency of patient examinations, family doctor communications and treatment of patients with pneumonia caused by SARS-Cov2. Materials and methods. We examined 23 families of 2–...

Full description

Saved in:
Bibliographic Details
Main Authors: V. P. Melnyk, O. V. Panasiuk, H. V. Sadomova-Andrianova, I. V. Antoniuk, I. O. Sliusarchuk, H. Ya. Solonynka
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2021-06-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/224926/232317
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850250003936706560
author V. P. Melnyk
O. V. Panasiuk
H. V. Sadomova-Andrianova
I. V. Antoniuk
I. O. Sliusarchuk
H. Ya. Solonynka
author_facet V. P. Melnyk
O. V. Panasiuk
H. V. Sadomova-Andrianova
I. V. Antoniuk
I. O. Sliusarchuk
H. Ya. Solonynka
author_sort V. P. Melnyk
collection DOAJ
description The aim of the study was identifying the features of infection in the site, clinical course of the disease, amount and frequency of patient examinations, family doctor communications and treatment of patients with pneumonia caused by SARS-Cov2. Materials and methods. We examined 23 families of 2–6 members (a total of 78), among them 41 patients with SARS-COV-2 pneumonia. The amount of patient examination (PCR, plain X-ray and CT of the thoracic cavity, coagulogram, blood oxygen saturation) and treatment extent (antibacterial, anticoagulant and oxygen therapy) were considered. Results. The contagiousness of the disease in the families of patients was from 33 % to 100%. The thoracic CT overuse: 73.3 % repeated, 33.0 % triple. Family doctors monitored the treatment only in 14.6 % of cases. The antibacterial therapy administration was 2 times more often than necessary; the treatment was changed by patients themselves or their acquaintances. A hospitalization was offered to patients with a decreased blood oxygen saturation of 92 % and below (29.3 %), and only 2 patients agreed to it. In a lack of treatment efficacy, the patients used respiratory fluoroquinolones (levofloxacin, moxifloxacin), meropenem, linezolid, amikacin, which are among the main drugs for the treatment of resistant tuberculosis. Extensive misuse of antibacterial drugs unnecessarily will result in an alarming increase in antibiotic-resistant infections after the COVID-19 pandemic. Conclusions. Pneumonia caused by SARS-COV-2 is a highly contagious disease in a family cluster (33–100 %). Routine administration of antibacterial drugs (especially levofloxacin, moxifloxanemine, meropenem, linezolid, amikacin) for patients with suspected SARS-COV-2 pneumonia by thoracic CT or PCR-confirmed without proven need is not only unnecessary, but even dangerous due to the potential increase in resistance to these drugs, which are the primary in the treatment of resistant tuberculosis. The anamnesis of the disease, oxyhemometry and coagulogram are of great importance when examining a patient with this pathology.
format Article
id doaj-art-8464a0dd61a64bb7b4ebcaa131db29fa
institution OA Journals
issn 2306-4145
2310-1210
language English
publishDate 2021-06-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Zaporožskij Medicinskij Žurnal
spelling doaj-art-8464a0dd61a64bb7b4ebcaa131db29fa2025-08-20T01:58:20ZengZaporizhzhia State Medical and Pharmaceutical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102021-06-0123339540110.14739/2310-1210.2021.3.224926Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settingsV. P. Melnyk0https://orcid.org/0000-0002-3400-9340O. V. Panasiuk1https://orcid.org/0000-0002-4271-9967H. V. Sadomova-Andrianova2https://orcid.org/0000-0002-1430-2435I. V. Antoniuk3https://orcid.org/0000-0002-9332-0614I. O. Sliusarchuk4https://orcid.org/0000-0001-6448-5332H. Ya. Solonynka5https://orcid.org/0000-0001-6733-9939PHEE “Kyiv Medical University”, UkrainePHEE “Kyiv Medical University”, UkrainePHEE “Kyiv Medical University”, UkrainePHEE “Kyiv Medical University”, UkrainePHEE “Kyiv Medical University”, UkrainePHEE “Kyiv Medical University”, UkraineThe aim of the study was identifying the features of infection in the site, clinical course of the disease, amount and frequency of patient examinations, family doctor communications and treatment of patients with pneumonia caused by SARS-Cov2. Materials and methods. We examined 23 families of 2–6 members (a total of 78), among them 41 patients with SARS-COV-2 pneumonia. The amount of patient examination (PCR, plain X-ray and CT of the thoracic cavity, coagulogram, blood oxygen saturation) and treatment extent (antibacterial, anticoagulant and oxygen therapy) were considered. Results. The contagiousness of the disease in the families of patients was from 33 % to 100%. The thoracic CT overuse: 73.3 % repeated, 33.0 % triple. Family doctors monitored the treatment only in 14.6 % of cases. The antibacterial therapy administration was 2 times more often than necessary; the treatment was changed by patients themselves or their acquaintances. A hospitalization was offered to patients with a decreased blood oxygen saturation of 92 % and below (29.3 %), and only 2 patients agreed to it. In a lack of treatment efficacy, the patients used respiratory fluoroquinolones (levofloxacin, moxifloxacin), meropenem, linezolid, amikacin, which are among the main drugs for the treatment of resistant tuberculosis. Extensive misuse of antibacterial drugs unnecessarily will result in an alarming increase in antibiotic-resistant infections after the COVID-19 pandemic. Conclusions. Pneumonia caused by SARS-COV-2 is a highly contagious disease in a family cluster (33–100 %). Routine administration of antibacterial drugs (especially levofloxacin, moxifloxanemine, meropenem, linezolid, amikacin) for patients with suspected SARS-COV-2 pneumonia by thoracic CT or PCR-confirmed without proven need is not only unnecessary, but even dangerous due to the potential increase in resistance to these drugs, which are the primary in the treatment of resistant tuberculosis. The anamnesis of the disease, oxyhemometry and coagulogram are of great importance when examining a patient with this pathology.http://zmj.zsmu.edu.ua/article/view/224926/232317pneumoniasars-cov-2familial foci of infectiondiagnosisoutpatient care
spellingShingle V. P. Melnyk
O. V. Panasiuk
H. V. Sadomova-Andrianova
I. V. Antoniuk
I. O. Sliusarchuk
H. Ya. Solonynka
Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings
Zaporožskij Medicinskij Žurnal
pneumonia
sars-cov-2
familial foci of infection
diagnosis
outpatient care
title Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings
title_full Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings
title_fullStr Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings
title_full_unstemmed Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings
title_short Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings
title_sort pneumonia caused by sars cov 2 diagnosis and treatment in outpatient settings
topic pneumonia
sars-cov-2
familial foci of infection
diagnosis
outpatient care
url http://zmj.zsmu.edu.ua/article/view/224926/232317
work_keys_str_mv AT vpmelnyk pneumoniacausedbysarscov2diagnosisandtreatmentinoutpatientsettings
AT ovpanasiuk pneumoniacausedbysarscov2diagnosisandtreatmentinoutpatientsettings
AT hvsadomovaandrianova pneumoniacausedbysarscov2diagnosisandtreatmentinoutpatientsettings
AT ivantoniuk pneumoniacausedbysarscov2diagnosisandtreatmentinoutpatientsettings
AT iosliusarchuk pneumoniacausedbysarscov2diagnosisandtreatmentinoutpatientsettings
AT hyasolonynka pneumoniacausedbysarscov2diagnosisandtreatmentinoutpatientsettings